A lawyer has outlined what he believes to be the most likely outcome if the U.S. Securities and Exchange Commission (SEC) wins against Ripple Labs and...
The synthetic biology boom of the pandemic era has become a synthetic biology bust. Many synthetic biology stocks promised the moon and delivered mud. It’s an...
AI is coming to biotech in a big way. From protein folding to drug screening, from studying cells to studying populations, the AI boom has long...
The stock market had a tremendous start to 2023. It might leave investors wondering what cheap blue-chip stocks are left to buy at reasonable prices. The...
Looking for investment opportunities in dividend stocks? Look no further! Discover the potential of cheap dividend stocks, undervalued dividend stocks, and high-yield cheap stocks that are...
The year got off to a rip-roaring start. The first half of 2023 saw spectacular gains in many stocks. The benchmark S&P 500 Index rose 16%...
Editor’s Note: Eric Fry here. Below, I have a special guest issue from InvestorPlace Senior Investment Analyst, Luke Lango to highlight his Primed Stocks Summit event...
During the first week of H2 2023, non-fungible token (NFT) sales witnessed a 23.39% decline compared to the previous week, marking a two-week downward trend. A...
The emergence of artificial intelligence is forcing a lot of people, companies, and even whole industries to rethink the way they fundamentally operate. One such industry...
Some stocks double in value over a short period of time as investors get excited about the future. Companies post strong earnings, come up with breakthrough...